News for MEDS Stock
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
TRxADE Health, Inc. Announces Special Cash Dividend
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
TRxADE Health, Inc. Announces Special Cash Dividend
Trxade health, Inc files its 3Q 10Q
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.
Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.
Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
EAT WELL GROUP TO SELL SAPIENTIA FOR USD $10 MILLION IN NASDAQ MERGER WITH MEDS & SUPERLATUS FOODS
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 15th at 6:00 p.m. Eastern Time
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 8th at 5:00 p.m. Eastern Time
TRxADE HEALTH Reports 16% Revenue Growth and Year End 2022 Financial Results
TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m. Eastern Time
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m. Eastern Time
TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal
TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program
TRxADE HEALTH Announces Termination of Public Offering of Common Stock
TRxADE HEALTH Announces Proposed Public Offering of Common Stock
TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr. Jeff Newell to its Advisory Board
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC
TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m. Eastern Time
Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services
TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial Results
TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m. Eastern Time
TRxADE HEALTH Reports Year End 2021 Financial Results
TRxADE HEALTH, INC. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
TRxADE HEALTH, INC. to Report Fourth Quarter and Year End 2021 Financial Results on Monday, March 28th at 5:00 p.m. Eastern Time
Coborn’s, Inc. and Bonum Health(TM) (A TRxADE HEALTH Company) Ink Telemedicine Deal To Deploy Deeply Discounted Telemedicine to Uninsured and Under-Insured Consumers
TRxADE Health Forms Joint Venture SOSRx.com to Expand Medication Accessibility via Manufacturer Partnerships
TRxADE HEALTH to Present at Aegis Virtual Conference
TRxADE HEALTH, INC. Announces Resumption of Modified Stock Repurchase Program
TRxADE HEALTH Announces Launch of Preferred Drug Discount Card as Part of New Health Services Organization Offering
TRxADE HEALTH to Present at LD Micro Movers Virtual Event on December 1, 2021
TRxADE HEALTH Reports Third Quarter 2021 Financial Results
TRxADE HEALTH to Report Third Quarter 2021 Financial Results on Monday, October 25th at 5:00 p.m. Eastern Time
TRxADE HEALTH to Present at LD Micro Main Event on October 12, 2021
TRxADE HEALTH to Present at Upcoming Investor Conferences in September
Bonum Health, a TRxADE Company, Launches Pre-Paid Digital Telemedicine Passes
TRxADE HEALTH Reports Second Quarter 2021 Financial Results
Winn-Dixie (Southeastern Grocers, Inc.) and Bonum Health(TM) (TRxADE HEALTH Company) Ink Telemedicine Deal
TRxADE HEALTH to Report Second Quarter 2021 Financial Results on Monday, July 26th at 4:30 p.m. Eastern Time
Big Y and Bonum Health(TM) (TRxADE HEALTH Company) to deploy New Telemedicine Program
TRxADE HEALTH, INC. Announces Launch of MedCheks Health Passport App for iOS Devices
TRxADE HEALTH, INC. Announces Authorization of Stock Repurchase Program
TRxADE HEALTH, INC to Present at LD Micro Invitational XI
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC.
TRxADE Group Announces Strategic Telehealth Partnership with Brookshire Grocery Company
TRxADE Group Announces Milestone Group Purchasing Agreement with QualityCare Pharmacies
Trxade Group Announces Launch of Government-Oriented Heath Passport Solution to Enable Expedited Post-COVID-19 Reopening
TRxADE Group Reports Record First Quarter 2021 Financial Results
Trxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern Time
TRxADE Group to Present at Planet MicroCap Showcase
TRxADE Group Reports Annual Revenue Growth of 130% and Year End 2020 Financial Results
Trxade Group to Report Fourth Quarter and Full Year 2020 Results on Monday, March 29th at 5:00 p.m. Eastern Time
Trxade Group to Present at March Investor Conferences
MedCheks LLC, a Trxade Group Company, to Launch Health Passport App Led by Industry Thought Leader James Ram
Trxade Group to Postpone Virtual Roadshow Presentation
Trxade Group to Host Virtual Roadshow on Wednesday, February 3, 2021 at 11:00 a.m. Eastern Time
Trxade Group Announces Strategic Telehealth Partnership with KPH Healthcare Services
TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational
TRxADE Group to Present at the Virtual Fall Investor Summit
Trxade Group Reports Record Third Quarter 2020 Financial Results
Trxade Group to Report Third Quarter 2020 Results on Monday, October 26th at 5:00 p.m. Eastern Time
Trxade Group Subsidiary Bonum Health Announces Prescription Savings Partnership with SingleCare
Trxade Group to Present at Upcoming Investor Conferences in September
Trxade Group Announces Launch of Bonum+ B2B Platform
Trxade Group Appoints Senior Healthcare Executive Ashton Maaraba as President of Bonum Health
Trxade Group Inc. Featured in Broadcast on Companies Aiding Coronavirus Front Lines
Trxade Group Reports Record Second Quarter 2020 Financial Results
Trxade Group, Inc. Withdraws Its Previously Filed FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit in Response To FDA Guidance
Trxade Group Inc. Featured in Editorial on Medical Supply Companies’ Critical Role in Coronavirus Battle
Back to Sitemap